CAM
UTHR icon

Capstone Asset Management’s United Therapeutics UTHR Stock Holding History

Capstone Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$784K Buy
6,047
+324
+6% +$40.4K 0.02% 681
2017
Q1 		$775K Buy
5,723
+316
+6% +$47.9K 0.02% 676
2016
Q4 		$776K Sell
5,407
-1,060
-16% -$135K 0.02% 678
2016
Q3 		$764K Sell
6,467
-445
-6% -$53.5K 0.02% 705
2016
Q2 		$732K Buy
6,912
+922
+15% +$103K 0.02% 705
2016
Q1 		$667K Buy
5,990
+541
+10% +$68.5K 0.02% 746
2015
Q4 		$853K Sell
5,449
-148
-3% -$21.5K 0.02% 651
2015
Q3 		$735K Buy
5,597
+601
+12% +$96.4K 0.02% 682
2015
Q2 		$869K Sell
4,996
-489
-9% -$88K 0.03% 640
2015
Q1 		$946K Buy
5,485
+262
+5% +$39.9K 0.03% 692
2014
Q4 		$676K Sell
5,223
-410
-7% -$52.8K 0.02% 853
2014
Q3 		$725K Buy
5,633
+110
+2% +$11.3K 0.02% 770
2014
Q2 		$489K Sell
5,523
-367
-6% -$35.3K 0.02% 1084
2014
Q1 		$554K Sell
5,890
-200
-3% -$20.5K 0.02% 987
2013
Q4 		$689K Sell
6,090
-3,637
-37% -$328K 0.02% 866
2013
Q3 		$767K Buy
9,727
+160
+2% +$11.7K 0.02% 967
2013
Q2 		$630K Buy
+9,567
New +$616K 0.02% 1026

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capstone Asset Management's UTHR Position: Q2 2017 in Review

Capstone Asset Management increased its United Therapeutics (UTHR) stake by 5.7% in Q2 2017, buying an estimated $40.4K and bringing the position to 6,047 shares worth $784K. The position accounts for 0.02% of the portfolio, ranked #681.

Capstone Asset Management first reported a position in UTHR in Q2 2013 and has held it in 17 quarters since. The position peaked at $946K in Q1 2015. 373 funds tracked by Wall St. Rank hold UTHR as of Q2 2017.

  • Capstone Asset Management held 6,047 shares of United Therapeutics worth $784K as of Q2 2017.
  • Capstone Asset Management bought 324 United Therapeutics shares in Q2 2017, an estimated $40.4K.
  • United Therapeutics made up 0.02% of Capstone Asset Management's portfolio in Q2 2017, its #681 holding.
  • Capstone Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's United Therapeutics position peaked at $946K in Q1 2015.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.